» Articles » PMID: 27551498

Mitochondrial Oligomers Boost Glycolysis in Cancer Stem Cells to Facilitate Blebbishield-mediated Transformation After Apoptosis

Overview
Date 2016 Aug 24
PMID 27551498
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis culminates in secondary necrosis due to lack of ATP. Cancer stem cells form spheres after apoptosis by evoking the blebbishield emergency program. Hence, determining how blebbishields avoid secondary necrosis is crucial. Here we demonstrate that N-Myc and VEGFR2 control transformation from blebbishields, during which oligomers of K-Ras, p27, BAD, Bax, and Bak boost glycolysis to avoid secondary necrosis. Non-apoptotic cancer cells also utilize oligomers to boost glycolysis, which differentiates the glycolytic function of oligomers from their apoptotic action. Smac mimetic in combination with TNF-α or TRAIL but not in combination with FasL abrogates transformation from blebbishields by inducing secondary necrosis. Thus blebbishield-mediated transformation is dependent on glycolysis, and Smac mimetics represent potential candidates to abrogate the blebbishield emergency program.

Citing Articles

C19MC drives nucleolar invasion of mitochondria and meiotic nuclear division in human cancers.

Jinesh G, Smallin M, Mtchedlidze N, Napoli M, Lockhart J, Flores E iScience. 2024; 27(11):111132.

PMID: 39563898 PMC: 11575172. DOI: 10.1016/j.isci.2024.111132.


Beyond Death: Unmasking the Intricacies of Apoptosis Escape.

Ergun S, Aslan S, Demir D, Kayaoglu S, Saydam M, Keles Y Mol Diagn Ther. 2024; 28(4):403-423.

PMID: 38890247 PMC: 11211167. DOI: 10.1007/s40291-024-00718-w.


Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.

Jinesh G, Brohl A Signal Transduct Target Ther. 2022; 7(1):296.

PMID: 35999218 PMC: 9399134. DOI: 10.1038/s41392-022-01132-6.


Mutant p53s and chromosome 19 microRNA cluster overexpression regulate cancer testis antigen expression and cellular transformation in hepatocellular carcinoma.

Jinesh G, Napoli M, Smallin M, Davis A, Ackerman H, Raulji P Sci Rep. 2021; 11(1):12673.

PMID: 34135394 PMC: 8209049. DOI: 10.1038/s41598-021-91924-7.


Targeting K-Ras and apoptosis-driven cellular transformation in cancer.

Godwin I, Anto N, Bava S, Babu M, Jinesh G Cell Death Discov. 2021; 7(1):80.

PMID: 33854056 PMC: 8047025. DOI: 10.1038/s41420-021-00457-5.


References
1.
Jinesh G, Laing N, Kamat A . Smac mimetic with TNF-α targets Pim-1 isoforms and reactive oxygen species production to abrogate transformation from blebbishields. Biochem J. 2015; 473(1):99-107. DOI: 10.1042/BJ20150877. View

2.
Taylor S, RESNICK R, Shalloway D . Nonradioactive determination of Ras-GTP levels using activated ras interaction assay. Methods Enzymol. 2001; 333:333-42. DOI: 10.1016/s0076-6879(01)33067-7. View

3.
Moon B, Jeong W, Park J, Kim T, Min D, Choi K . Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. J Natl Cancer Inst. 2014; 106(2):djt373. DOI: 10.1093/jnci/djt373. View

4.
Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins J . Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 2000; 14(19):2501-14. PMC: 316970. DOI: 10.1101/gad.836800. View

5.
Adhikary S, Eilers M . Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 2005; 6(8):635-45. DOI: 10.1038/nrm1703. View